Royalty Pharma (RPRX) Asset Utilization Ratio (2020 - 2026)

Royalty Pharma (RPRX) has 7 years of Asset Utilization Ratio data on file, last reported at 0.12 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 2.05% year-over-year to 0.12; the trailing twelve-month figure through Mar 2026 stood at 0.12 (down 2.05% YoY), and the FY2025 full-year result was 0.13, down 3.93% from the prior year.
• Asset Utilization Ratio rose to 0.12 in Q1 2026, from 0.12 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.15 in Q4 2023 to a low of 0.12 in Q4 2025.
• A 5-year average of 0.13 and a median of 0.13 in 2022 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio rose 12.59% in 2023 and retreated 14.54% in 2024, its largest moves.
• Tracing RPRX's Asset Utilization Ratio over 5 years: stood at 0.13 in 2022, then climbed by 12.59% to 0.15 in 2023, then fell by 14.54% to 0.12 in 2024, then fell by 2.22% to 0.12 in 2025, then advanced by 1.4% to 0.12 in 2026.
• Business Quant data shows RPRX's Asset Utilization Ratio at 0.12 in Q1 2026, 0.12 in Q4 2025, and 0.12 in Q3 2025.